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Abstract
The mouse mammary tumor viruses (MMTVs) that induce mammary adenocarcinomas in mice are transmitted from mother to offspring
through milk. MMTV infection results in the deletion of specific T cells as a consequence of interaction between the MMTV-encoded
superantigen (Sag) and specific V chains of the T cell receptor. The specificity and kinetics of T cell deletion for a number of highly
oncogenic MMTVs, such as C3H- and GR-MMTVs, have been studied in great detail. Some work has also been done with the MMTVs
expressed in two substrains of RIII mice, BR6 and RIIIS/J, but the nature of the interaction between T cells and the virus(es) that the parental
RIII-strain of mice express has not been investigated. Since RIII mice (designated henceforth as RIII/Sa) have a very high incidence
(90–98%) of mammary tumors, and they have been extensively used in studies of the biology of mammary tumor development, we have
presently determined the pattern of V-T cell deletion caused by RIII/Sa-MMTV-Sag(s) during viral infection. T cells were isolated from
lymph nodes and thymus of young RIII/Sa mice, as well as from BALB/c (BALB/cfRIII/Sa), C57BL (C57BLfRIII/Sa), and RIIIS/J
(RIIIS/JfRIII/Sa) mice after they were infected with RIII/Sa-MMTV(s) by foster nursing. The composition of the T cells was analyzed by
FACS using a panel of monoclonal antibodies specific to a variety of Vs. Our results show that milk-borne RIII/Sa-MMTV(s) infection
leads to the deletion of CD4 V-2, and to a lesser extent V-8 bearing peripheral and central T cells in RIII/Sa, RIIIS/J, BALB/c, and
C57BL mice. Our results are in contrast to the findings that C3H-, GR-, and BR6-MMTVs delete V-14- and/or V-15-specific T cells.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Mouse mammary tumor virus (MMTV) is the etiologic
agent of mammary adenocarcinomas in mice (Nandi and
McGrath, 1973; Moore et al., 1979). In most strains of mice,
tumorigenic MMTVs transmit exogenously through milk,
but in a few mouse strains the virus particles can be trans-
mitted endogenously via the germ line. A unique feature of
MMTV is that it exploits the immune system of the host for
pathogenesis. The involvement of the immune system in
MMTV-induced mouse mammary tumorigenesis was sus-
pected as early as 1964 when neonatal thymectomy was
found to reduce the incidence of mammary tumor develop-
ment (Martinez, 1964). Subsequently, T cells were shown to
play a role in MMTV infection of mammary cells in vivo
(Tsubura et al., 1988). It is now well established that the
antigen (superantigen, Sag) that interacts with the immune
system in MMTV-infected mice is a product of the long
terminal repeat (LTR) of the virus (Choi et al., 1991). The
existence of this product was recognized initially by se-
quence analysis of the LTR and by in vitro translation
studies of the viral RNA (Donehower et al., 1981; Dickson
and Peters, 1981; Sen et al., 1981). Sag is a type II trans-
membrane protein that contains a small NH2-terminal intra-
cellular domain and a large extracellular COOH-terminus
that interacts with the V portion of the T cell receptor
(Korman et al., 1992; Yazdanbakhsh et al., 1993; McMahon
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and Bogatzki, 1997). Sequence comparisons of the Sag
proteins from some 35 endogenous and exogenous MMTV
strains have shown striking similarities at the N-terminals,
but there are two polymorphic regions in the C-terminal
amino acids, 164 to 198, and from 288 to the C-terminus
(Brandt-Carlson et al., 1993; Wrona et al., 1998). Variabil-
ity in the amino acid sequence of this region among differ-
ent MMTVs seems to be the determinant for contacts with
different V chains of the T cell receptor (TCR), for the
induction of specific V T cell proliferation when they are
recognized as foreign, or for the deletion, during shaping of
the immune repertoire, of the same subset of lymphocytes
when they are present as products of endogenous MMTVs
(for review see Held et al., 1994; Ross, 1998).
The Sags of endogenous and exogenous MMTVs have
been grouped into several distinct families according to
their V specificity. This specificity correlates strongly with
the observations that certain Sag molecules react with par-
ticular TCRs. The Sags are highly homologous within a
given family but polymorphic between different families.
MMTV Sags also differ in their abilities to induce a vigor-
ous or a weak T cell response in a particular host. It is now
well established that most, if not all, endogenous MMTVs,
located on different chromosomes and heterogeneously dis-
tributed from one strain of mice to another, express their
Sag genes irrespective of whether or not the transcripts of
these proviruses are packaged into virions, and play some
role in mammary tumor development. While the role of the
Sags of exogenous viruses has been attributed to the sur-
vival of the virus through T cell-dependent expansion of
infected B cells, the consequence of the expression of the
Sags of endogenous MMTVs and the resultant deletion of
specific V T cells has been shown to provide the mice
some protection from infection by exogenous viruses with
the same Sag specificity (Golovkina et al., 1992). In addi-
tion, the Sags of some nonpathogenic endogenous MMTV
proviruses in certain strains of mice seem to contribute to
viral propagation and tumor induction by copackaging with
pathogenic exogenous or endogenous MMTVs (Golvkina et
al., 1994, 1996, 1997). Examples exist that show that vi-
ruses with similar Sag specificity do not necessarily share
similar biological activity. For example, the Japanese labo-
ratory mouse strains CS and NC carry two unique endoge-
nous MMTVs, Mtv-48 and Mtv-51, encoding similar T cell
deletion ligands for V-2, but only one of these proviruses
(Mtv-48) produces milk-borne MMTVs (Niimi et al., 1995).
The endogenous proviruses Mtv-7, Mtv-43, and Mtv-50
as well as the exogenous MMTVs, JYG and SW, share the
same V-6, -7, -8.1, and -9 specificity, but these viruses
differ significantly in their biological properties (McMahon
and Bogatzki, 1997; Held et al., 1992; Nishio et al., 1994).
For example, while both MMTV-SW and MMTV-JYG
induce vigorous Sag-dependent T cell response in vivo after
injection into native BALB/c mice, the MMTV-SW, unlike
the MMTV-JYG, fails to induce mammary tumors (Held et
al., 1992; Sarkar et al., 1994). The MMTVs, such as C3H
and GR, that produce mammary tumors at a very high
incidence in their natural hosts and/or in other strains of
mice infected with these viruses have been shown to delete
V-14 and/or V-15 (Marrack et al., 1991; Acha-Orbea et
al., 1991). Footpad injection of MMTVs obtained from the
milk of RIIIS/J mice, a derivative of cross-breeding between
RIII and SEC/1ReJ mice, has also been shown to stimulate
the proliferation of V-14 T cells (Wajjwalku et al., 1995).
This study neither addressed the question of whether RIIIS/
J-MMTV Sag causes central and/or peripheral deletion of
V-14 T cells nor analyzed the structure of the Sag. Simi-
larly, the structure of the Sag of a milk-borne MMTV
carried by a substrain of RIII mice (BR6), derived from a
crossing between an RIII male and a C57BL female mouse
(Foulds, 1949), has been determined, but its V T cell
specificity has not been ascertained. The pathobiology of
the MMTVs that the parental RIII mice express in their milk
and/or in the tumors that they develop has been studied
more extensively than the milk-borne viruses of BR6 and
RIIIS/J mice (Moore et al., 1979). Surprisingly, no work has
been done to determine how RIII-MMTV(s) infection mod-
ulates the V T cell repertoire in susceptible hosts. Here, we
demonstrate that the MMTV(s) that parental RIII mice (des-
ignated hence forth as RIII/Sa) express in their milk, unlike
those viruses produced by the RIIIS/J and BR6 mice, delete




Four strains of mice, RIII/Sa, RIIIS/J, BALB/c, and
C57BL, were used in this study. The progeny of a mammary
tumor-bearing RIII female mouse on her fourth parity were
isolated in 1974 and maintained as a separate lineage, des-
ignated RIII/Sa, in the laboratory of one of us (N.H.S.) at
the Memorial Sloan-Kettering Cancer Center (MSKCC),
New York. MSKCC obtained RIII mice from the laboratory
of Dan Moore of the Institute of Medical Research, Cam-
den, NJ. Records show that Dr. Moore received his RIII
mice in 1950 from the laboratory of Dobrovolskia-Zavads-
kaia (Hilkens et al., 1981) and that he maintained the mouse
colony by brother–sister mating (Moore et al., 1979). The
RIII/Sa mice used in this study have also been maintained
since 1974 by brother–sister mating of young adults from
high-parity mothers (third or more). These mice develop
mammary tumors at a very high incidence (90%). RIIIS/J,
BALB/c, and C57BL mice were obtained from Jackson
Laboratory and were raised at the Medical College of Geor-
gia. Although no recent data are available, RIIIS/J mice
were known to carry both endogenous and exogenous
MMTVs and to have a high incidence of mammary tumors
(Schlom et al., 1973; Wajjwalku et al., 1995). BALB/c and
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C57BL mice do not carry any exogenous MMTVs and
rarely develop mammary tumors.
Virus infection via foster nursing and evaluation of TCR
V T cell deletion by antibody staining and flow
cytometry
To determine the pattern of V T cell deletion in RIII/Sa
mice, as well as in other strains of mice, such as BALB/c,
RIIIS/J, and C57BL infected with RIII/Sa-MMTV, lympho-
cytes obtained from these mice were analyzed. The latter
groups of mice were infected by foster nursing of their
newborn pups to RIII/Sa mothers. Lymphocytes obtained
from the thymus of RIII/Sa mice were also analyzed to
ascertain if MMTV infection resulted in central T cell de-
letion. T cells were analyzed for the expression of various
mouse Vs with the following monoclonal antibodies: anti-
V-2 (B20.6), -V-3 (KJ25a), -V-4 (KT-4-10), -V-5
(MR9-4), -V-6 (RR4-7), -V-7, -V-8.1/V-8.2 (KJ16),
-V-8.2 (F23.2), -V-8x (F23.1), -V-9 (MR10-2), -V-10
(KT10b.2), -V-11 (RR3-15), -V-12, -V-13, V-14 (14-
2), and anti-TCR, H57-597. Most of the anti-V antibodies
used were from our own laboratory (L.I.); the antibodies
raised against V-7, -V-12, and -V-13 were purchased
from PharMingen. Lymph node derived T cells were stained
with each one of the abovementioned FITC-conjugated V-
specific MAbs and PE-conjugated anti-CD4 (GK1.5) anti-
body, as previously described (Ignatowicz et al., 1992;
Scherer et al., 1995; Xu et al., 1996). At least 15,000 cells
were analyzed on a FACScalibur (Becton–Dickinson,
Mountain View, CA). The cells from the thymus were
stained with anti-CD8 antibodies, in addition to the anti-
CD4-, -V-2-, V-8x-, V-8.1-.2-, V-8.2-, and V-14-
specific antibodies. The percentage of V-specific T cells
was calculated from the total number of CD4-positive cells.
Virus infection by footpad injection
Milk was aspirated from third-parity RIII/Sa mice with
the help of a mechanical pump, and virus was semipurified
by centrifugation as described previously (Sarkar and
Moore, 1970). One hundred microliters of a fivefold viral
concentrate was injected into the four fatpads (25 l/pad) of
8-10-week-old MMTV (exogenous)-negative BALB/c
mice. Four days after virus administration, mice were killed;
draining lymph nodes were harvested, and the cells were
analyzed by flow cytometry.
Results
TCR-V expression in RIII/Sa and RIIIS/J mice
In view of the fact that RIII/Sa and RIIIS/J mice were
derived from a high mammary tumor incidence mouse
strain, RIII, we assumed that both RIII/Sa and RIIIS/J carry
the same strain of MMTV(s) and thus virus infection should
affect the expression of TCR-Vs in a similar manner.
Preliminary analyses of splenic CD4-positive T cells from
4- to 6-week-old female mice showed significant differ-
ences in their distribution of V-2, V-3, V-4, V-5,
V-6, V-8, V-11, V-12, V-13, and V-14 T cells
(Fig. 1). Compared to RIII/Sa mice, RIIIS/J mice exhibited
the presence of a much higher percentage of CD4-positive T
cells carrying V-2, V-4, and V-14. A reversal of this
pattern of expression was found with V-3, V-5, V-6,
V-8, V-11, V-12, and V-13. The pattern of distribu-
tion of the various V-carrying CD4-positive T cells from
8- to 10-week-old mice was found to be primarily similar to
the pattern exhibited by the T cells from 4- to 6-week-old
mice (data not shown). However, there was some decrease
in the percentage of V-2- and V-8-expressing T cells in
8- to 10-week-old RIII/Sa mice compared to 4- to 6-week-
old mice. The difference thus observed between the patterns
of V expression among the RIII/Sa and RIIIS/J mice was
Fig. 1. TCR-V repertoire of CD4-positive T cells in 4 to 6 week-old
RIII/Sa and RIIIS/J mice. Cells from draining popliteal lymph nodes were
harvested and stained with PE-labeled anti-CD4 and FITC-labeled anti-V
antibodies. Cells were then analyzed on a FACS CALIBUR flow cytom-
eter. Each column represents the mean number of CD4-positive T cells and
standard deviation of three to five mice. A: specificity for TCR V-2, -3,
-4, -5, -6, and -7; B: specificity for TCR V-8, -9, -10, -11, -12, -13,
and -14.
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quite broad and we could not draw any conclusion as to
whether or not the two mouse strains express the same or
different endogenous and/or exogenous MMTV strains. The
results probably reflected the diversity in the genetic back-
ground between the RIII/Sa and RIIIS/J mice.
Identification of the Vs associated with RIII/Sa-MMTV
infection
To analyze the effect of virus infection in mice free of
milk-borne MMTV, newborn BALB/c mice, which have
been shown to be susceptible to infection by a variety of
MMTV strains, were foster-nursed by RIII/Sa females. At
6-8 weeks of age, the foster-nursed females were sacrificed,
and cells from lymph nodes as well as T cell enriched
splenocytes were harvested and analyzed by flow cytometry
for a variety of TCR V expression on CD4-positive T
cells. Similar experiments were done with the splenocytes
from BALB/c mice that were not exposed to RIII/Sa-
MMTV. It was found that virus infection resulted in the
deletion of V-2-expressing T cells in BALB/c mice by
more than 95% (Fig. 2A); V-8-expressing T cells were
also found to be deleted by approximately 56% (Fig. 2B).
By contrast RIII/Sa mice foster-nursed on BALB/c mice did
not show any deletion of either V-2- nor V-8-expressing
T cells (data not shown). These observations indicated that
the virus(es) that RIII/Sa mice shed in their milk interacted
with V-2- and V-8-specific T cells.
It has been shown previously that foster-nursing as well
as inoculation of milk samples or purified virus particles
from the milk of parental RIII mice cause productive infec-
tion to C57BL mice (for review, see Moore et al., 1979).
Therefore, we investigated whether or not RIII/Sa-MMTV
infection would induce deletion of V-2- and V-8-specific
T cells in this strain of mice. C57BL mice were foster-
nursed on third-parity RIII/Sa mice. T cells were harvested
from 6- to 8-week-old animals and analyzed using V-2-
and V-8-specific antibodies; V-14-specific antibody was
used as a control. A second control experiment involved a
group of BALB/c mice. These mice were foster-nursed on
third-party RIII/Sa mothers that were the sisters of those
mice used for foster-nursing the C57BL pups. This was
done to minimize possible differences in the amounts of
virus particles available for infection in the two groups of
C57BL and BALB/c mice. As shown in Fig. 3A and B,
RIII/Sa-MMTV deleted both V-2- and V-8-specific T
cells in both mouse strains, but the extent of V-2 T cell
deletion appeared to be less dramatic in C57BL mice than
what we observed in BALB/c mice. RIII/Sa-MMTV(s) also
appeared to induce a lower level of V-8-specific T cell
deletion in C57BL mice than in BALB/c mice. Since the
anti-V-8 antibody used in these experiments contained
also V-8.1 and V-8.2, we used two other TCR V-8-
related antibodies that were available to us: one contained
both V-8.1 and V-8.2 specificity, while the other was a
monoclonal antibody against TCR V-8.2. As shown in
Fig. 3A and B, RIII/Sa-MMTV infection resulted in V-8.2,
and possibly V-8.1-specific T cell deletion in both
BALB/c and C57BL mice. This observation suggests that
both Ad/As and Ed molecules can present the RIII/Sa-
MMTV(s) Sag.
As shown in Fig. 1, RIIIS/J mice carry a larger popula-
tion of V-2, V-4, and V-14 T cells compared to RIII/Sa
mice, and since V-2-specific T cells are one of the targets
for the RIII/Sa-MMTV-Sag(s), we investigated whether
RIIIS/J mice could be infected with RIII/Sa-MMTV(s).
Deletion of V-2-specific T cells was used as a marker for
viral infection. RIIIS/J pups were foster-nursed by RIII/Sa
mothers. Six to eight-week-old pups were sacrificed; lymph
node T cells were prepared, stained with anti-V-2, -V-3,
-V-4, -V-10, and V-14 T cell specific antibodies, and
analyzed by flow cytometry. The results showed that more
than 90% of only V-2-specific T cells were deleted in
Fig. 2. The effect of milk-borne RIII/Sa-MMTV(s) infection on the
TCR-V repertoire in BALB/C mice. Newborn BALB/c pups were re-
moved from their mothers and foster-nursed on RIII/Sa mothers. Popliteal
lymph-node cells were harvested from 6-to-8-week-old foster-nursed mice,
stained for CD4-positive T cells and for the expression of their V gene
products, and analyzed by flow cytometry. Same age group BALB/c mice
nursed by their own mothers were used as controls. Note that significant
deletion of T cells carrying only V-2 (P  0.005) and V-8 (P  0.01)
specificity occurred in those BALB/c mice that were exposed to the milk
of RIII/Sa mice. Data are expressed as mean and standard deviation (error
bars) for three to five mice. A: specificity for TCR V-2, -3, -4, -5, -6, and
-7; B: specificity for TCR V-8, -9, -10, -11, -12, -13, and -14.
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those groups of mice that were fed with RIII/Sa mouse milk
(Fig. 4). This indicates that RIIIS/J mice are highly suscep-
tible to RIII/Sa-MMTV(s).
Several investigators have shown that injection into adult
mice of bacterial superantigen, MMTV-containing milk, or
semipurified virus preparations results in an early increase
in the proportion of T cells expressing the V products that
are specific for that superantigen. To evaluate further the
specificity of T cell response in vivo to milk-borne
MMTV(s) of RIII/Sa mice, exogenous MMTV-free adult
BALB/c mice were injected with semipurified virus that
was obtained from the milk of RIII/Sa mice or with PBS as
controls. Four days later draining lymph nodes were har-
vested from both the experimental and the control groups.
The lymph nodes from the experimental groups of mice
were found to be two- to threefold enlarged compared to
those mice that were injected with PBS. Flow cytometric
analyses of the lymph node cells revealed that MMTV
injection resulted in a dramatic increase in those T cells that
were expressing TCR V-2. The proportion of T cells
expressing V-8 was also found to be increased in the
MMTV-infected mice. However, the relative increase in
TCR V-8 cells was lower than that exhibited by the TCR
V-2 cells. There was no increase in other TCR V cells,
including the TCR V-14 cells (Fig. 5). These results may
indicate that RIII/Sa mice express two different strains of
infectious MMTVs, one of which interacts with V-2 cells,
while the other strain of virus interacts with V-8 cells.
Alternatively, these mice may carry only one strain of
MMTV that interacts with both TCR V-2 and V-8 cells
(see Discussion).
Time course of T cell deletion with RIII/Sa-MMTV
infection
Different strains of MMTVs have been shown to produce
different deletion patterns of TCR V cells in the infected
animals. Exogenous C3H- and GR-MMTVs appear to in-
duce a slow deletion of T cells expressing V-14 (Marrack
et al., 1991; Acha-Orbea et al., 1991; Ignatowicz et al.,
1992). By contrast, the time course of V-2 cell deletion
caused by BALB/cV-MMTV has been described to be sig-
nificantly more rapid compared to both C3H- and GR-
MMTVs (Ando et al., 1995). These observations prompted
us to evaluate the deletion kinetics of both V-2 and V-8
cells in BALB/c and RIIIS/J mice after they were infected
with milk-borne RIII/Sa-MMTVs by foster nursing. Our
results show that, in general, RIII/Sa-MMTV(s) induces
rapid deletion of V-2 T cells not only in the parental
RIII/Sa mouse strain, but also in BALB/c and RIIIS/J strains
of mice (Fig. 6). It should be noted, however, that the
kinetics of deletion in these latter strains of mice were found
Fig. 4. Demonstration for the deletion of TCR V-2 CD4-positive T cells
in RIIIS/J mice infected with RIII/Sa-MMTV. Newborn RIIIS/J pups were
foster-nursed by third-parity RIII/Sa mice and their lymph nodes were
examined at the age of 6–8 weeks for the presence of CD4-positive T cells
carrying TCR V-2, -3, -4, -10, and -14. RIIIS/J pups nursed by their own
mothers were used as controls. The experimental conditions and data
analyses were the same as those described in Fig. 2 (also see text for
details). Note that the lymph nodes of RIIIS/JfRIII/Sa mice contained
approximately 85% fewer TCR V-2 (CD4-positive) T cells than the
lymph nodes of RIIIS/J mice (controls); the percentage of other TCR V-T
cells in both the control and the experimental groups were comparable.
Fig. 3. Comparative studies of the levels of TCR V-2- and V-8-specific
CD4-positive T cell deletions in C57BL (A) and BALB/c (B) mice exposed
to RIII/Sa mouse milk. In this experiment, newborn pups from both C57BL
and BALB/c mice were foster-nursed by a group of RIII/Sa mothers
(sisters) of the same parity (third). C57BL and BALB/c pups nursed by
their own mothers were used as controls. The experimental conditions and
data analyses were the same as those described in Fig. 2 (also see text for
details).
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to be more rapid than in RIII/Sa mice. That the deletion of
V-2 T cells is specific to milk-borne RIII/Sa-MMTV(s)
was further confirmed by analyzing the status of these cells
in those RIII/Sa mice that were foster-nursed by BALB/c
mice. The RIII/SafBALB/c mice did not show any evidence
of V-2 T cell deletion within the period of 20 weeks that
we examined.
The time-course deletion of V-8 cells in BALB/c mice
infected with RIII/Sa-MMTV(s) showed a somewhat differ-
ent pattern; the kinetics appeared to be slow (Fig. 7). This
was also found to be true in RIII/Sa mice. It should be
mentioned that we could not evaluate the kinetics of V-8
T cell deletion in RIIIS/J mice because of the fact that the
percentage of V-8 cells in this strain of mice, as compared
to RIII/Sa and BALB/c mice, is very low (see Figs. 1B and
2B). Taken together, it appears that RIII/Sa mice express in
their milk a strain(s) of MMTV(s) that induces in the virus-
infected host a rapid deletion of V-2 T cells and a rela-
tively slow deletion of V-8 T cells.
RIII/Sa-MMTV infection induces deletion of central
T cells
The results of our investigation into the deletion patterns
of peripheral TCR V T cells as shown above led us to
address the question of whether or not RIII/Sa-MMTV
infection also induces clonal deletion of V-2 and/or V-
8-expressing immature thymocytes. T cells were prepared
from thymus of 4-, 10-, and 16-week-old RIII/Sa mice that
were raised by their own mothers producing milk-borne
RIII/Sa MMTVs. CD4 and CD8 T cells were stained for
Fig. 5. Proliferative response of V-2 and V-8-specific CD4-positive T
cells in adult BALB/c mice exposed to semipurified preparations of
MMTV from the milk of third-parity RIII/Sa mice. Eight-to-ten-week-old
BALB/c mice (free of milk-borne MMTV) were injected in the footpads
with MMTV. Control mice were injected with PBS. Four days later,
animals from both groups were sacrificed, and draining lymph nodes were
harvested. Lymph node cells were analyzed by flow cytometry for the
proportion of CD4-positive TCR V-2 and V-8 T cells. As control, the
effect of virus infection on TCR V-14 T cells was also analyzed. Data
represent the mean number of cells and standard deviation for four indi-
vidually analyzed mice. Note that TCR V-2 T cells were expanded
approximately by 3.6-fold (P  0.001), whereas TCR V-8 T cells were
expanded by only a factor of 1.4-fold (P  0.01).
Fig. 6. Kinetics of TCR V-2 T cell deletions in spontaneously MMTV(s)-
infected RIII/Sa mice, and in experimental RIII/Sa-MMTV(s)-infected
BALB/c (BALB/cfRIII/Sa) and RIIIS/J (RIIIS/JfRIII/Sa) mice. Exogenous
MMTV-negative BALB/c and RIIIS/J mice were used as controls. Other
control animals used were RIII/SafBALB/c; the removal of RIII/Sa-
MMTV(s) in these mice was done by foster-nursing RIII/Sa pups to
BALB/c mice. Data are expressed as the mean and standard deviation of
four mice.
Fig. 7. Kinetics of TCR V-8 T cell deletions in spontaneously MMTV(s)-
infected RIII/Sa mice and in experimentally RIII/Sa-MMTV(s)-infected
BALB/c (BALB/cfRIII/Sa) mice. Control animals included BALB/c and
RIII/SafBALB/c mice. Data are expressed as the mean and standard devi-
ation of four mice.
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the expression of V-2, V-8, and V-14. Flow cytometric
analyses revealed that the thymus of virus-infected 16-
week-old RIII/Sa mice contained significantly lower num-
bers of CD4 and CD8 TCR V-2 cells than the thymus
of 4-week-old mice (Table 1). The reactivity of the viral
superantigen to CD4 cells appeared to be stronger than to
the CD8 V-2 T cells. This reduction of the T cells seems
to be virus specific since, as expected, we did not see any
changes in the proportion of TCR V-14 cells in our virus-
infected mice of different ages. TCR V-14 cells have been
shown to be deleted in mice infected with C3H-MMTV.
Our results also show that T cells carrying V-8, V-8.1/
8.2, or V8.2 also suffer from deletion as a consequence of
RIII/Sa-MMTV infection. However, the response of these
particular subsets of T cells was much weaker than the TCR
V-2-expressing T cells. Overall, our data suggest that
RIII/Sa-MMTV(s) infection induces deletion of not only
peripheral mature T cells, but also of immature thymocytes.
Discussion
The initial events that facilitate MMTV infection of
mouse mammary glands involve B cell infection followed
by the expression of the viral superantigen, Sag, as a type II
transmembrane glycoprotein at the B cell surface (Held et
al., 1994). This allows the Sag-positive B cells to interact
with CD4 T cells that express the appropriate Sag-reactive
TCR V domain. The outcome of such an interaction is the
release of cytokines by T cells, enhanced proliferation of
Sag-presenting B cells which facilitates the amplification of
viral infection, and subsequent deletion of cognate T cells.
In the present study, we have shown that the viruses (RIII/
Sa-MMTVs) that RIII/Sa mice shed in their milk induce in
the offspring the deletion of CD4 T cells expressing V-2
and V-8.1–8.3. Furthermore, experimental transmission of
the virus in BALB/c, C57BL, and RIIIS/J, another strain of
RIII-derived mice, also leads to the deletion of these two
subsets of T cells. This finding is surprising because another
virus, BR6-MMTV (often refered to as RIII-MMTV),
which is shed in the milk of BR6 mice (a line derived from
RIII mice) has been reported to delete V-14 T cells (Xu et
al., 1996). Similarly, one study has suggested the involve-
ment of V-14 T cells in RIIIS/J mice, a third subline of
RIII mice that is thought to be infected with a milk-borne
RIII-MMTV (RIIIS/J-MMTV) (Wajjwalku et al., 1995). In
addition, although RIII-, C3H-, and GR-MMTVs have long
been considered to be standard MMTV strains (Nandi and
McGrath, 1973; Moore et al., 1979), unlike RIII/Sa-
MMTV, both C3H- and GR-MMTVs have also been shown
to induce the deletion of T cells expressing V-14 (Xu et
al., 1996; Ignatowicz et al. 1992). Two other strains of
MMTVs, BALB14 and II-TES14 expressed in BALB/c and
II-TES mice, respectively, have also been shown to bear
V-14 specificity (Golovkina et al., 1997; Ando et al.,
1995).
A survey of the experimental results obtained by a large
panel of investigators on the deletion patterns of the V T
cell repertoire as a consequence of the expression of various
exogenous and endogenous MMTV-Sags shows relation-
ships between the interaction of a particular population(s) of
V T cells with the Sags of an MMTV(s) having specific
C-terminal amino acid sequences (Held et al., 1993; Frankel
et al., 1991; Dyson et al., 1991; Woodland et al., 1991;
Marrack et al., 1991). This type of finding allows one to
suspect what MMTV strain is expressed in an unknown
MMTV model in which the deletion of specific V T cells
has been experimentally determined, and vice versa. On the
basis of this assumption, it could be hypothesized that our
RIII/Sa mice most likely express two different strains of
MMTVs belonging to two different virus groups with V-2
and V-8 specificities (see Fig. 8). We have tentatively
designated the V-2-specific RIII-virus as RIII/Sa-
MMTV-I and the V-8-specific virus as RIII/Sa-MMTV-2.
It should be mentioned that we have cloned two different
species of Sag-cDNAs by RT-PCR amplification of milk-
borne viral RNA and determined their sequences (data not
shown; see GenBank Accession Nos. AF136898 and
AF136899). A comparison of the C-terminal 30 amino acids
of the Sags of these virions with those from other V-2- and
V-8-specific MMTVs (Fig. 8) indeed indicate that at least
two different strains of MMTVs are expressed in the milk of
RIII/Sa mice.
The RIII/Sa-MMTV-1 strain corresponds to a group of
both endogenous and exogenous viruses that include
Table 1
Percentage of CD4 and CD8 T cells expressing V-2, V-8,
V-8.1/8.2, V-8.2, and V-14 in the thymus of RIII/Sa mice
infected neonatally with milk-borne RIII/Sa-MMTV(s)
TCR V
CD4/CD8 4-week-old mice 10-week-old mice 16-week-old mice
V-2
CD4 6.7  1.2 5.0  1.1 1.8  0.3**
CD8 5.4  0.8 4.1  0.5 1.5  0.2**
V-8
CD4 22.6  1.0 21.6  1.0 15.9  0.5*
CD8 23.1  1.4 24.2  1.2 16.9  0.3*
V-8.1/8.2
CD4 14.2  0.9 12.9  1.1 9.7  0.5*
CD8 18.2  1.0 18.9  0.9 11.5  0.4*
V-8.2
CD4 13.6  0.9 10.4  0.7 9.2  0.6*
CD8 8.47  0.7 13.2  1.0 8.9  0.6
V-14
CD4 4.2  0.4 6.6  0.6 6.3  0.8
CD8 3.8  0.3 4.1  0.5 5.4  0.5
Note. At the indicated ages, mice were killed and T cells were prepared
from thymus and analyzed by two-parameter flow cytometry for TCR V
expression on CD4 and CD8 cells. Data represent the mean number of
T cells from three individually analyzed mice. Deletion of CD4 V-2
cells were significant by Student’s t-test at P  0.005 (**) in 16-week-old
animals as compared to the 4-week-old mice.
* Significant at P  0.01.
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BALB/cV, BALB2, C3H-K, C4, CS/Mtv-48, Mtv-DDO,
and II-TES2. These viruses are expressed in a variety of
mouse strains and interact with V-2 T cells (Wrona et al.,
1998). Interestingly, the II-TES2 MMTV-expressing TES2
mice that were derived by cross-breeding between DBA/2
and Japanese pet mice (Wajjwulku et al., 1995) have been
shown to express another viral strain, MMTV-II-TES14
(Ando et al., 1995). Similarly, the BALB2-MMTV-express-
ing BALB/cT (subline 7) mice, maintained at the National
Institutes of Health, Frederick Cancer Research Facility,
express another MMTV strain, MMTV-BALB14 (Golovkina
et al., 1997). In terms of viral expression our RIII/Sa mice
thus resemble TES2 and BALB/cT mice. However, while
the Sag of MMTV-II-TES2 and MMTV-BALB2, similar to
RIII/Sa-MMTV-1, interacts with V-2 T cells, the other
viral strains (MMTV-II-TES 14 and MMTV-BALB 14),
unlike RIII/Sa-MMTV-2, target the V-14 T cells. It should
be pointed out that the similarity of the C-terminal se-
quences between different MMTV strains does not neces-
sarily reflect their pattern of viral expression, the nature of
the Sag interaction with V-T cells, and the biological
consequences of viral infection. For example, Mtv-48 and
Mtv-51, which have been shown to be present in Japanese
mouse strains CS and NC, respectively, are completely
identical in their orf sequences, but unlike Mtv-48, Mtv-51 is
incapable of producing a milk-borne virus (Niimi et al.,
1995). The C3H-K virus was identified in a colony of
BALB/c mice that had been foster nursed on C3H-MMTV-
positive mothers (Wellinger et al., 1986). The C-terminal
sequences of this virus are nearly identical to BALB/cV-
MMTV, but the virus, although expressed in mammary
glands, does not induce mammary tumors (Rollini et al.,
1992).
Many of the endogenous and exogenous MMTVs have
been shown to require major MHC class II-I-E expression
for clonal deletion and stimulation. The classic examples for
such a requirement is exhibited by two standard exogenous
MMTV strains, the C3H- and GR-MMTVs (Ross, 1998).
However, other exogenous viruses, such as BALB/cV and
MMTV-C4, as well as the endogenous MMTV-DDO, do
not depend on I-E expression for clonal deletion and stim-
ulation (Shakhov et al., 1993; Kang et al., 1993; Jouvin-
Marche et al., 1993; Tomonari et al., 1993; Hodes et al.,
1993). It has been suggested that strong superantigens do
not depend on MHC Class II I-E expression for clonal
deletion and stimulation, and that the kinetics of clonal
deletion may be correlated with the strength of superanti-
genic activity (Held et al., 1994). For example, MMTV-
DDO induces vigorous stimulation and fast kinetics of
clonal deletion, whereas MMTV-CS induces vigorous stim-
ulation but slow kinetics of clonal deletion, despite the fact
that the C-terminal amino acid sequences of these two
viruses are nearly identical (Jouvin-Marche et al., 1993).
Our results suggest that RIII/Sa-MMTV-1 infect both
BALB/c (H-2d I-E) and C57BL (H-2b I-E) mice, imply-
ing that the Sag of this virus has a broader superantigenic
specificity than the other members of this group of MMTVs,
such as MMTV-II-TES2, the SAg of which requires MHC
class II I-E molecules exclusively for antigen presentation
(Ando et al., 1995).
As shown in the present study, the second virus that
RIII/Sa mice express in their milk interacts with V-8-
specific T cells. Deletion of a specific subset of T cells
carrying V-8.1 has been shown to be induced as a conse-
quence of the Sag expression of a relatively large group of
endogenous and exogenous MMTVs consisting of Mtv-7,
SW, Mtv-50, Mtv-43, JYG, FM, SHN, as well as Mtv-44
(Ross, 1998). The majority of this virus group also deletes
V-6, -7, and -9 (Mtv-7, SW, Mtv-50, Mtv-43, JYG). An
exceptionally polymorphic pattern of V-T cell deletion is
exhibited by FM-MMTV. Unlike the other viruses in this
group, the Sag of this virus appears to interact with both
Fig. 8. Identity RIII/Sa-MMTV-1 and RIII/Sa-MMTV-2, expressed in the milk of RIII/Sa mice, with other MMTV strains with TCR V-2 or V-8 T cell
specificity and/or nearly identical C-terminal amino acids of the MMTV-Sag molecules. That RIII/Sa-MMTV-1 and RIII/Sa-MMTV-2 carry the specificity
for the deletion of TCR V-2 and V-8 T cells, respectively, were experimentally determined in the present study. The C-terminal amino acid sequences
of these two MMTV strains were derived from GenBank (Accession Nos. AF136898 and 136899). Information for V-specificity and alignment of the last
30 amino acids of the Sags of other MMTVs were obtained from published reports (for example, see Wrona et al., 1998). Note that neither of the two
RIII/Sa-MMTV strains show similarity with BR6-MMTV. Gaps (shown as dashes) were introduced to maximize amino acid identities and the dots indicate
identical amino acids. The astericks indicate the position of the stop codons.
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TCR V-2 and V-14 cells. Because of the fact that the
C-terminal 30–40 amino acids of the Sags of different
MMTV strains are variable and correlated strikingly with
recognition of particular TCR V chains, how it is possible
that the Sag of FM-MMTV interacts with such a variety of
TCR V cells, particularly the TCR V-2 and V-14 cells?
Our MMTV-2 virus seems to interact with only V-8-
specific T cells, despite the fact that our preliminary results
show that the C-terminal amino acids sequences of this
virus resemble very closely the Sag sequences of FM-
MMTV (Yoshimoto et al., 1994, 1996; Upragarin et al.,
1997). It is possible that FM mice may express multiple
strains of MMTVs, each of which interact with distinct
subsets of V T cells. The following observations may
support this idea. First, the C-terminal amino acid sequences
of the Sag of FM-MMTV differ significantly from the Sag
sequences of the two distinct groups of MMTVs (C3H, GR,
BR6, II-TES14, and BALB14; and BALB2, C4, MMTV-
DDO, II-TES2, CS/MTV-48, and BALB/cV) with exclu-
sive recognition for the V-2- and V-14-specific T cells.
Second, our present work has shown that RIII/Sa mice
express at least two distinct strains of MMTVs. This is
consistent with the observations that other mouse strains,
such as II-TES and CS, have been shown to express more
than one MMTV strain. Finally, as suggested previously,
new MMTV strains may be generated in some mouse
strains via recombination of endogenous and exogenous
viruses. It is, therefore, most likely that many, if not all of
the available mouse strains, may express multiple MMTV
strains. This raises an important biological question for
those mouse models in which multiple strains of viruses are
expressed: does each viral strain contribute to mammary
tumor development? We are currently addressing this ques-
tion in our RIII/Sa mouse model.
Our finding that the viruses that RIII/Sa mice express in
their milk interact with V-2- and V-8-specific T cells is
unexpected because previous studies with two other sub-
lines, BR6 and RIIIS/J, derived from the original RIII
mouse strain, have shown that both mouse lines express
only one viral strain, the Sag of which interacts only with
V-14-specific T cells in a manner similar to that exhibited
by C3H- and GR-MMTVs. Indeed the Sag sequences of
BR6-MMTV are similar to the Sag sequences of C3H- and
GR-MMTVs (Ross, 1998). Transfer of GR-MMTV in the
form of an endogenous Mtv-2 provirus from GR mice to
wild mice, free of both endogenous and exogenous
MMTVs, also results in the deletion of V-14-specific T
cells (Morris et al., 1986; Ferrick et al., 1992). Since the Sag
sequences of the putative RIIIS/J-MMTV was not reported
in the work that showed the effect of RIIIS/J mouse milk on
the deletion of V T cells (Wajjwalku, 1995), we do not
know the nature of the virus that these mice were expressing
at the time of the experiments. Surprisingly, however, we
could not confirm that the presently available RIIIS/J mice
do indeed express V-14-specific MMTV in their milk. Our
results show that V-14-specific T cells are not deleted in
RIIIS/J mice (data not shown), and thus they may not
produce any GR- or C3H-like MMTV particles in their
milk. This view is consistent with the fact that RIIIS/J mice
have currently been described in the Jackson Laboratory
catalog as nonproducers of mammary tumors. It should be
emphasized further that RIIIS/J mice differ significantly
from RIII/Sa mice in that they have the largest known
deletion of the TCR V genes: V-8 and V-5 gene sub-
families, along with V-6, V-9, V-11, V-12, V-13,
V-15, and V-17 (Haqqi et al., 1989).
Presently, we cannot offer a definitive explanation for the
apparent structural and biological differences observed be-
tween the MMTVs produced by RIII/Sa, RIIIS/J, and B6
mice, all of which were derived from the same mouse strain,
RIII. It is quite likely, however, that the breeding history of
these mice may have contributed to this problem. The
RIII/Sa mice are the direct decendents of the parental RIII
strain and thus should carry the wild-type RIII-MMTV. The
BR6 mice were derived by breeding a C57BL female mouse
with an RIII male (Foulds, 1949). This should have pre-
vented any milk-borne RIII virus from transmission to the
resultant offsprings, and thus the BR6 virus may represent a
rarely expressed MMTV that was in the milk of that par-
ticular C57BL mouse.
The way the RIIIS/J mice were derived involved a num-
ber of breeding steps. Around 1967, neither RIII/J nor
RIII/AnJ mice (same as RIII, with a high incidence of
mammary tumors) were able to produce viable young at The
Jackson Laboratory. Thus the laboratory bred an RIII/AnJ
female with a male SEC/1ReJ mice (unrelated to RIII, but
related to C3H; known to produce milk-borne MMTV and
having a high incidence of mammary tumors; Staats, 1976).
An F1 female from this cross was bred to an RIII/J male
mice (see JAX’s website: Http://jaxmice.jax.org/jaxmice-
cgi / / jaxmicedb.cgi?obj typepricedeta i l&stock) .
Inbreeding of the resultant pups continued. This substrain
was initially called RIII/2J, but is presently known as
RIIIS/J (Sweeney et al., 1990). The breeding protocol might
have contributed to the deletion of a large number of TCR
V genes in this strain (Haqqi et al., 1989). It was expected
that RIIIS/J mice would retain the milk-borne RIII-MMTV,
and indeed RIIIS/J mice were described to produce MMTV
(Schlom et al., 1973; Wajjwalku et al., 1995). However,
since the TCR V-specificity of RIIIS/J virus has been
shown to be similar to C3H-, GR-, and BR6-MMTVs (Wa-
jjwalku et al., 1995), it might have evolved through recom-
bination between a putative endogenous MMTV and an
exogenous RIII virus.
As shown in the present study, the RIIIS/J mice, how-
ever, are highly susceptible to RIII/Sa-MMTV-2 virus in-
fection which results in rapid deletion of TCR V-2 T cells.
Thus the RIIIS/J mouse model offers a unique opportunity
for the isolation of RIII/Sa-MMTV-2 that is expressed to-
gether with RIII/Sa-MMTV-1 in the milk of RIII/Sa mice.
Pups of RIIIS/J mice could be foster-nursed by RIII/Sa
mice, or young RIIIS/J animals could be injected with milk
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samples collected from RIII/Sa mice. RIIIS/J mice thus
exposed to the milk of RIII/Sa mice are expected to be
infected by RIII/Sa-MMTV-2, but not by RIII/Sa-
MMTV-1, because these mice lack TCR V-8 T cells, the
target cells that are needed for the establishment of infection
by RIII/Sa-MMTV-1.
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